Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,096 | -2,498 | -8,230 | -4,430 | -2,895 |
| Depreciation Amortization | 1 | 1 | 2 | 2 | 1 |
| Accounts receivable | -47 | -72 | -236 | -175 | -146 |
| Other Working Capital | -290 | 76 | 195 | 530 | 671 |
| Other Operating Activity | 825 | 402 | 861 | 569 | 327 |
| Operating Cash Flow | $-5,607 | $-2,092 | $-7,408 | $-3,504 | $-2,042 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,811 | 104 | 3,389 | 2,914 | 2,914 |
| Common Stock Repurchased | N/A | N/A | -100 | -56 | -56 |
| Other Financing Activity | -1 | 15 | -57 | -50 | -50 |
| Financing Cash Flow | $4,811 | $119 | $3,232 | $2,808 | $2,808 |
| Exchange Rate Effect | 14 | -1 | -32 | -31 | -8 |
| Beginning Cash Position | 13,437 | 13,437 | 17,645 | 17,645 | 17,645 |
| End Cash Position | 12,654 | 11,463 | 13,437 | 16,917 | 18,402 |
| Net Cash Flow | $-783 | $-1,974 | $-4,208 | $-728 | $758 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,607 | -2,092 | -7,408 | -3,504 | -2,042 |
| Free Cash Flow | -5,607 | -2,092 | -7,408 | -3,504 | -2,042 |